Stocks dropped after Donald Trump ordered that U.S. companies find alternatives to their operations in China.US Marketsread more
"We don't need China and, frankly, would be far better off without them," Trump tweeted.Politicsread more
Multinationals that rely on the supply chain from China are tumbling after President Donald Trump ordered them find alternatives to their Chinese operations.Marketsread more
President Trump again rips into Federal Reserve Chairman Jerome Powell, comparing him to Chinese President Xi Jinping.Politicsread more
China says the new tariffs will begin Sept. 1 and Dec. 15. That's when President Trump's latest tariffs on Chinese goods are to take effect.Marketsread more
Powell repeats his pledge to keep the economic expansion going while acknowledging that tariffs and other factors are causing growth to slow.The Fedread more
In a series of tweets Friday, Trump called on American companies to look for "an alternative to China," singling out FedEx, UPS, Amazon and the U.S. Postal Service...Transportationread more
The Koch brothers financed one of the most influential political networks in the modern era. The sprawling political empire includes conservative and libertarian nonprofits...Politicsread more
The president tweeted Friday morning that he was ordering "our great American companies" to "immediately start looking for an alternative to China."Marketsread more
These are the stocks posting the largest moves in midday trading.Market Insiderread more
The two American car companies are among the top exporters of U.S.-produced vehicles to China along with BMW and Daimler/Mercedes-Benz, according to industry data obtained by...Autosread more
Billionaire investor Carl Icahn on Tuesday urged Cigna shareholders to vote against the health insurer's $52 billion purchase of Express Scripts, citing regulatory hurdles and the growing threat of Amazon.com.
The Cigna-Express Scripts deal has drawn investor skepticism over concerns that Amazon.com Inc's entry into healthcare will upend the sector, which is already reeling from President Donald Trump's push to lower drug prices.
"When Amazon starts to compete as we believe they will, with their 100 million Prime users and scale distribution system, they will have no trouble breaking into the so-called ecosystem," Icahn wrote in a letter to Cigna shareholders.
"Competitive risk from Amazon, arguably the strongest competitor in the world, will be an existential threat to pharmacy benefit managers like Express Scripts, possibly challenging their very existence."
Icahn also said the Trump administration's push to scale back rebates that PBMs receive from drug manufacturers will hurt their profitability.
The billionaire investor, who has a long position on Cigna and a short position on Express Scripts, said in a letter titled "Cigna's $60 billion folly" that the insurer was overpaying for Express Scripts.
Icahn said Cigna should instead repurchase its shares and pursue partnership with existing pharmacy benefit managers, including Express Scripts.
Icahn has not disclosed his stake in Cigna, but The Wall Street Journal reported on Monday that the investor and his affiliates own about 0.56 percent of the company.
Express Scripts' shares fell last week after the news of Icahn's stake and his opposition to the deal first emerged. Cigna on Thursday said it was confident of winning shareholder approval for its Express Scripts deal. The shareholder vote is due on Aug. 24.
"We strongly believe that the combination (with Express Scripts) is in the best interest of our shareholders," Cigna Chief Executive Officer David Cordani reiterated last week.
Express Scripts shares were down 2 percent in heavy premarket trading, while Cigna shares were untraded.
"We believe we are well positioned for growth and remain confident in the deal," Express Scripts spokesman Brian Henry said. Cigna was not immediately available for comment.
Analysts do not expect shareholders to support Icahn, noting that few shareholders have questioned the strategic rationale of the deal and cited significant overlap in shareholding, with Cigna shareholders through various funds also owning nearly 84 percent of Express Scripts.
"We still expect that Icahn will find it challenging to build support among Cigna shareholders," Leerink analyst Ana Gupte wrote in a note on Monday.